I think the company should make a statement that highlights the potential of Mesenchymal stem cells (MSCs) and that they are being shown to possess a comprehensive powerful immunomodulatory function in COVID-19.
This is not to mislead but to actually raise awareness of the mechanism and the patents they possess.
Cantor Update - MSC's and COVID-19, page-3
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.000(0.00%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1759 | $1.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.28 | 4000 | 1 |
View Market Depth
| Last trade - 10.02am 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable